Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs - PubMed (original) (raw)
doi: 10.1038/ni827. Epub 2002 Aug 5.
Affiliations
- PMID: 12154358
- DOI: 10.1038/ni827
Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs
Shin-ichiro Fujii et al. Nat Immunol. 2002 Sep.
Abstract
Natural killer T (NKT) lymphocytes mediate a rapid reaction to the glycolipid drug alpha-galactosylceramide (alpha GalCer), which triggers release of large amounts of cytokines into the serum within 12 h, starting with interleukin 4 (IL-4). When alpha GalCer is administered to mice on dendritic cells (DCs) instead, the response is more prolonged (>4 days) and marked by a large expansion in IFN-gamma-producing NKT cells as well as greater resistance to metastases of the B16 melanoma. Nevertheless, DCs from mice given free alpha GalCer are able to induce strong IFN-gamma-producing NKT responses when transferred to naïve mice, but not when transferred to alpha GalCer-treated recipients. In the latter, the NKT cells are energized and can respond to glycolipid only in the presence of supplemental IL-2. Therefore, when alpha GalCer is selectively targeted to DCs, mice develop a stronger, more prolonged and effector type of NKT response, but this response can be blocked by the induction of anergy after presentation of alpha GalCer on other cells.
Similar articles
- Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S, Shimizu K, Hemmi H, Steinman RM. Fujii S, et al. Immunol Rev. 2007 Dec;220:183-98. doi: 10.1111/j.1600-065X.2007.00561.x. Immunol Rev. 2007. PMID: 17979847 Review. - IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
Maeda M, Yanagawa Y, Iwabuchi K, Minami K, Nakamaru Y, Takagi D, Fukuda S, Onoé K. Maeda M, et al. Immunobiology. 2007;212(7):537-47. doi: 10.1016/j.imbio.2007.03.007. Epub 2007 May 1. Immunobiology. 2007. PMID: 17678711 - Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K. Hayakawa Y, et al. Eur J Immunol. 2001 Jun;31(6):1720-7. Eur J Immunol. 2001. PMID: 11385616 - Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A. Kawakami K, et al. Infect Immun. 2001 Nov;69(11):6643-50. doi: 10.1128/IAI.69.11.6643-6650.2001. Infect Immun. 2001. PMID: 11598033 Free PMC article. - Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.
Seino K, Fujii S, Harada M, Motohashi S, Nakayama T, Fujisawa T, Taniguchi M. Seino K, et al. Springer Semin Immunopathol. 2005 Jun;27(1):65-74. doi: 10.1007/s00281-004-0194-y. Epub 2005 Jan 14. Springer Semin Immunopathol. 2005. PMID: 15650847 Review.
Cited by
- invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.
Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin RS. Boonchalermvichian C, et al. Front Transplant. 2024 May 6;3:1353803. doi: 10.3389/frtra.2024.1353803. eCollection 2024. Front Transplant. 2024. PMID: 38993780 Free PMC article. Review. - Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer.
Nelson A, McMullen N, Gebremeskel S, De Antueno R, Mackenzie D, Duncan R, Johnston B. Nelson A, et al. Breast Cancer Res. 2024 May 15;26(1):78. doi: 10.1186/s13058-024-01818-5. Breast Cancer Res. 2024. PMID: 38750591 Free PMC article. - Control of the Development, Distribution, and Function of Innate-Like Lymphocytes and Innate Lymphoid Cells by the Tissue Microenvironment.
Ikuta K, Asahi T, Cui G, Abe S, Takami D. Ikuta K, et al. Adv Exp Med Biol. 2024;1444:111-127. doi: 10.1007/978-981-99-9781-7_8. Adv Exp Med Biol. 2024. PMID: 38467976 Review. - Insights into the heterogeneity of iNKT cells: tissue-resident and circulating subsets shaped by local microenvironmental cues.
Cui G, Abe S, Kato R, Ikuta K. Cui G, et al. Front Immunol. 2024 Feb 19;15:1349184. doi: 10.3389/fimmu.2024.1349184. eCollection 2024. Front Immunol. 2024. PMID: 38440725 Free PMC article. Review. - Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells in situ.
Yamasaki S, Shimizu K, Fujii SI. Yamasaki S, et al. Front Immunol. 2024 Feb 1;15:1345037. doi: 10.3389/fimmu.2024.1345037. eCollection 2024. Front Immunol. 2024. PMID: 38361934 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources